Loading organizations...
§ Venture Capital · Beijing, China
Manages onshore and offshore funds, focusing on asset management growth with over 8 billion RMB AUM onshore by 2020.
Hongcheng Investment operates as an investment firm dedicated to managing onshore funds and collaborating on offshore fund launches, with a strategic emphasis on achieving rapid growth in asset management across diverse sectors. The firm has demonstrated significant expansion in its operational scale, overseeing more than 8 billion RMB in onshore assets under management (AUM) by 2020, reflecting its accelerated development. Its strategy includes broadening its investment reach through various initiatives, notably a partnership with OPIM to facilitate the introduction of offshore funds to a wider investor base. While details regarding specific portfolio companies or external lead investors are not widely disclosed, the firm's primary activities revolve around comprehensive asset management and fund development. Hongcheng Investment was founded in April 2015 by Zhang Tao.
Hongcheng Investment has 1 tracked investment across 1 company. The latest tracked deal is $73.9M Series C in IASO Biotherapeutics in January 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 18, 2023 | IASO Biotherapeutics | $73.9M Series C | — | Efung Capital, Housen Care Brothers, Nanjing Jiangbei NEW Area State Owned Asset Management, Shanghai Guoxin Investment & Development, Shanghai Waigaoqiao Free Trade Zone Group |